These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1604581)

  • 1. RS-61443 prevents graft-versus-host disease but not rejection in allogeneic rat small bowel transplants.
    Sonnino RE
    Transplant Proc; 1992 Jun; 24(3):1190. PubMed ID: 1604581
    [No Abstract]   [Full Text] [Related]  

  • 2. Small bowel transplantation in rats using RS-61443: effect on GVHD and rejection.
    Shaffer D; Blakely ML; Gottschalk R; Monaco AP
    Transplant Proc; 1992 Jun; 24(3):1159-60. PubMed ID: 1604568
    [No Abstract]   [Full Text] [Related]  

  • 3. Heterotopic rat intestinal transplantation: effect of cyclosporine and RS-61443 on graft-vs-host disease and rejection.
    D'Alessandro AM; Rankin MA
    Transplant Proc; 1994 Jun; 26(3):1611-2. PubMed ID: 8030056
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of a new immunosuppressant, CAM, on small bowel transplantation in rats.
    Sawada H; Kaihara S; Egawa H; Inomata Y; Tanaka K; Yamaoka Y
    Transplant Proc; 1996 Oct; 28(5):2512-3. PubMed ID: 8907928
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of rapamycin on orthotopic small bowel transplantation in the rat.
    Chen H; Wu J; Xu D; Aboujaoude M; Stepkowski S; Kahan B; Daloze P
    Transplant Proc; 1992 Jun; 24(3):1157-8. PubMed ID: 1604567
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination therapy with FK 506 and RS61443 for rejection following allogeneic small bowel transplantation in rats.
    Yoshida S; Toyama Y; Aoki T; Nakamura J; Odaira H; Inagaki Y
    Transplant Proc; 2000 Nov; 32(7):2492-3. PubMed ID: 11120262
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of FK506 and RS61443 for reversal of small-bowel rejection.
    Stangl MJ; Gräb C; Fischer T; Mebert H; Weiss M; Hammer C
    Transpl Int; 1992; 5 Suppl 1():S274-7. PubMed ID: 14621800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor pretreatment with anti-T-cell receptor monoclonal antibodies prevents graft-vs-host disease in brequinar-treated small bowel allograft recipients.
    Wang M; Stepkowski SM; Kahan BD
    Transplant Proc; 1995 Feb; 27(1):383. PubMed ID: 7879029
    [No Abstract]   [Full Text] [Related]  

  • 9. Fulminant graft-versus-host disease after FK 506 treatment in fully allogeneic small bowel transplantation.
    de Bruin RW; HogenEsch H; Heineman E; Jeekel J; Marquet RL
    Transplant Proc; 1991 Dec; 23(6):3257-9. PubMed ID: 1721429
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversal of experimental small bowel transplantation rejection with cyclosporine A.
    Liu Q; Yang R; Grosfeld JL; Collins MH; Pescovitz MD
    Transplant Proc; 1996 Oct; 28(5):2508-9. PubMed ID: 8907925
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolongation of pancreas allograft survival by mycophenolate mofetil in the rat.
    Qi S; Chen H; Xu D; Daloze P
    Transplant Proc; 1996 Apr; 28(2):932-3. PubMed ID: 8623468
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of graft-versus-host disease by RS-61443 in two different rodent models.
    Shaffer D; Muanza T; Blakely ML; Simpson MA; Monaco AP
    Transplantation; 1993 Jan; 55(1):221-3. PubMed ID: 8420055
    [No Abstract]   [Full Text] [Related]  

  • 13. 2-Chlorodeoxyadenosine in combination with cyclosporine prevents rejection after allogeneic small bowel transplantation.
    Schmid T; Oberhuber G; Thaler W; Kaltenbacher A; Herbst P; Margreiter R; Konwalinka G
    Transplant Proc; 1994 Jun; 26(3):1614. PubMed ID: 7913269
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanism of graft-versus-host disease and inhibition with deoxyspergualin on small bowel transplantation in rats.
    Tanaka S; Okada H; Uda K; Fujioka M; Makabe M; Orita T; Orita K
    Transplant Proc; 1992 Jun; 24(3):1161-3. PubMed ID: 1604569
    [No Abstract]   [Full Text] [Related]  

  • 15. Leflunomide immunosuppression in rat small intestinal transplantation.
    Foster PF; Xiao F; Kociss K; Chong AS; Sankary HN; McChesney L; Cohn S; Williams JW
    Transplant Proc; 1994 Jun; 26(3):1599-600. PubMed ID: 8030053
    [No Abstract]   [Full Text] [Related]  

  • 16. Host vs graft and graft vs host reactions after allogeneic heterotopic small bowel transplantation in the rat.
    Gasser M; Prange K; Schroeder P; Stoffregen C; Eckstein V; Deltz E
    Transplant Proc; 1992 Jun; 24(3):1128-9. PubMed ID: 1604550
    [No Abstract]   [Full Text] [Related]  

  • 17. Cycloprodigiosin hydrochloride as an immunosuppressant in rat small bowel transplantation.
    Nakai K; Hamada Y; Kato Y; Yamamoto D; Hirata H; Hioki K
    Transplant Proc; 2000 Sep; 32(6):1324-5. PubMed ID: 10995968
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral leflunomide prevents small bowel allograft rejection in the rat.
    He G; McAlister VC; Lee TD; Bitter-Suermann H; Theal M; Wright J; MacDonald AS
    Transplant Proc; 1994 Jun; 26(3):1613. PubMed ID: 8030057
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of different forms of recipient antigen and different routes of antigen administration in donor pretreatment for preventing graft-versus-host disease in rat small bowel transplantation.
    He G; Wang M; Xu H; Tian L; Yu J; Stepkowski SM; Kahan BD
    Transplant Proc; 1996 Oct; 28(5):2469. PubMed ID: 8907906
    [No Abstract]   [Full Text] [Related]  

  • 20. Donor pretreatment with rapamycin delays rejection following intestinal allotransplantation.
    He G; Zhong R; Zhang Z; Garcia B; Black R; Duff J; Grant D
    Transplant Proc; 1992 Jun; 24(3):1178. PubMed ID: 1604577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.